Ophthalmologic manifestations in leukemia
Keywords:
DeCS, ocular manifestations, leukemia, ophthalmology, hematologyAbstract
Introduction: leukemias are a group of neoplastic diseases characterized by an abnormal proliferation of white blood cells. The ocular abnormalities observed in these patients may be varied and include those affecting the eyeball and / or its annexes.
Objective: to present the main ophthalmologic manifestations in leukemia.
Method: a search of the main scientific papers in recent years, as well as the printed literature that includes this topic, where the most important were selected to prepare the content of the final report.
Results: ophthalmologic manifestations in patients suffering from leukemia are grouped into three groups: primary leukemic manifestations or caused by infiltration of blast cells, manifestations of secondary origin related to changes observed in the hematological profile of these patients and the secondary manifestations of complications due to anti-leukemia treatment.
Conclusions: it is essential that doctors specializing in ophthalmology and hematology are informed and trained to detect various eye disorders associated with leukemic diseases, since an accurate and timely diagnose can improve its management and may be significant not only for the visual health of these patients, but also, for their lives.
Downloads
References
1. Greer JP. Wintrobe´s Clinical Hematology. 13th ed. New York: Lippincott Williams Wilkins; 2013:3188.
2. American Cancer Society. Leukemia. Atlanta, Ga: American Cancer Society; c2015 [actualizado 2015 May 12; citado 2016 Ene 15]. [aprox. 65 pantallas]. Disponible en: http://www.cancer.org/acs/groups/cid/documents/webcontent/002289-pdf.pdf
3. Hoffman R. Hematology: Basic Principles and Practice. 6th ed. Canada: Elsevier S.A; 2013:886-1202.
4. Novoa V, Núñez NA, Carballo OG, Lessa CF. Inmunofenotipos aberrantes en leucemias agudas en una población hospitalaria de Buenos Aires. Medicina (B. Aires) [Internet]. 2013 Feb [citado 2016 Ene 16]; 73(1): 9-16. Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802013000100002&lng=es.
5. Marsán-Suárez V, del Valle-Pérez L, Socarrás-Ferrer BB, Sánchez-Segura M, Macías-Abraham C, Mazorra-Hererra Z, et al. Validación del ultramicrométodo inmunocitoquímico (UMICIQ) para el inmunofenotipaje de la leucemia linfoide aguda pediátrica. Rev Cubana Hematol Inmunol Hemoter [Internet]. 2012 Sep [citado 2016 Ene 10]; 28(3): 282-88. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892012000300010&lng=es.
6. Chocron IM, Morrison DG, Friedman DL, Desai NA, Donahue SP. Ophthalmic manifestations of relapsing acute childhood leukemia. Journal of AAPOS [Internet]. 2015 Jun [citado 2016 Feb 17]; 19(3): 284-86. Disponible en: https://www.clinicalkey.es/#!/content/journal/1-s2.0-S1091853115000841?scrollTo=%231-s2.0-S1091853115000841-gr1
7. García Bernal M, Badell Serra I. Leucemia en la infancia: signos de alerta. An Pediatr Contin [Internet]. 2012 Dic [citado 2016 Feb 17]; 10(1): 1-7. Disponible en: http://apps.elsevier.es/watermark/ctl_servlet?_f=10&pident_articulo=80000654&pident_usuario=0&pcontactid=&pident_revista=51&ty=14&accion=L&origen=apccontinuada&web=www.apcontinuada.com&lan=es&fichero=v10n1a554pdf001.pdf
8. González Gilart G, Salmon Gainza SL, Querol Betancourt N, Jiménez Portuondo N, Sell Lluveras M. Características clínico epidemiológicas de las leucemias en el niño. MEDISAN [revista en la Internet]. 2011 Dic [citado 2016 Feb 17]; 15(12): 1714-19. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192011001200005&lng=es.
9. Ahn ES, Tarabishy AB, Schachat AP. Posterior Pole Manifestations of Hematologic Diseases. New York: Springer; 2013.
10. Dones GM, Devesa SS, Curtis RE. Acute leukemia incidence and patients survival among children and adults in the United States, 2001-2007. Blood 119(1):34-43, 2012.
11. Paulsson K, Lilljebjorn H, Biloglav A, Olsson L, Rissler M, Castor A, et al. The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukemia. Nat Genet [Internet]. 2015 Jun [citado 2016 Mar 1]; 47(6): 672-6. Disponible en: https://www.clinicalkey.es/#!/content/medline/2-s2.0-25961940
12. Lassaletta Atienza A. Leucemias. Leucemia linfoblástica aguda. Madrid. Pediatr Integral [Internet]. 2012 [citado 2016 Mar 1]; 16(6): 453-62. Disponible en: http://www.pediatriaintegral.es/numeros-anteriores/publicacion-2012-07/leucemias-leucemia-linfoblastica-aguda/
13. Violeta Cádiz D, Alfonso Urzúa M, Myriam Campbell B. Calidad de vida en niños y adolescentes sobrevivientes de leucemia linfoblástica aguda. Rev Chil Pediatr [Internet]. 2011[citado 2016 Mar 15]; 82 (2): 113-21. Disponible en: http://web.a.ebscohost.com/ehost/pdfviewer/pdfviewer?sid=7c0a8d11-6c84-4b47-a6f9-d74e833327ed%40sessionmgr4004&vid=0&hid=4101.
14. Morales-Peralta A, Covarrubias-Espinoza G, Rendón-García H, Larios-Farak TC. Supervivencia en niños con Leucemia Aguda Linfoblástica tratados en base a factores de riesgo inmunomoleculares. Bol Clin Hosp Infant Edo Son [Internet]. 2014 [citado 2016 Mar 1]; 31(2); 90-9. Disponible en: http://web.a.ebscohost.com/ehost/pdfviewer/pdfviewer?sid=aaeea304-0847-4ec9-a9a8-9d2910be3797%40sessionmgr4004&vid=0&hid=4101.
15. González-Otero A, Menéndez-Veitía A, Machín-García S, Svarch E, Campo-Díaz M, Fernández-Nodarse R, et al. Resultados del tratamiento de la Leucemia Linfoide Aguda del niño en Cuba. Rev Cubana Hematol Inmunol Hemoter [Internet]. 2014 Mar [citado 2016 Abr 7]; 30(1): 36-46. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892014000100006&lng=es.
16. Fuentes M, Rojas-Patricio ED, Ocqueteau M, Bertin P, Sarmiento M, et al. Resultados en el tratamiento de pacientes con leucemia mieloide aguda no promielocítica en el Hospital Clínico de la Pontificia Universidad Católica entre los años 2010-2014. Rev. méd. Chile [Internet]. 2015 Oct [citado 2016 May 16]; 143(10): 1269-76. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872015001000005&lng=es. http://dx.doi.org/10.4067/S0034-98872015001000005.
17. Campos-Campos LE, Mendoza-Altamirano L, Pérez Casillas RX, Beauregard-Escobar AM, Calderón Alvarado LM. Alteraciones oculares en pacientes pediátricos con leucemia aguda. Rev Mex Oftalmol [Internet]. 2004 Nov-Dic [citado 2016 Abr 7]; 78(6): 287-90. Disponible en: http://www.medigraphic.com/pdfs/revmexoft/rmo-2004/rmo046d.pdf
18. Bengoa A, Julve A, Moreno L, Izquierdo C, Lago MD, Sáenz N, et al. Manifestaciones oftalmológicas de enfermedades sistémicas. En: Gutiérrez Díaz A. Atlas en urgencias en Oftalmología: Esteve. Barcelona: Editorial Glosa; 2003; II. 74-6.
19. Riordan-Eva P, Whitcher J. Vaughan & Asbury's General Ophthalmology. 18th ed. USA: The McGraw-Hill Companies; 2012:336.
20. Shah SB, Reichstein DA, Lally SE, Shields CL. Persistent bloody tears as the initial manifestation of conjunctival chloroma associated with chronic myelogenous leukemia. Graefes Arch Clin Exp Ophthalmol. 2013; 251:991–92
21. Méndez-Cepeda P, Millán-Rodríguez AC, Dios E, Álvarez C, Sevillano C. Sarcoma granulocítico conjuntival en leucemia mieloblástica aguda M1. Arch Soc Esp Oftalmol [Internet]. 2012 Mar [citado 2016 Abr 20]; 87(3): 79-81. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0365-66912012000300003&lng=es.
22. Welschen D. Sarcoma melanocítico de órbita como manifestación de leucemia. Oftalmol Clin Exp. 2013; 6(2): 53-60.
23. Lombardi V, Pedrini F, Casas G, Riveros D, Stengel FM. Sarcoma mieloide: presentación cutánea de novo. Arch. Argent. Dermatol. 2013 63: 13-16
24. American Academy of Ophthalmology. Clinical and basic science course: Intraocular inflammation and Uveitis. 2014-2015. San Francisco: The Eye MD Association; 2014:285.
25. Arias-Cabello B, Ordaz- Favila JC, Juarez-Echenique JC. Infiltración de ambos nervios ópticos en leucemia linfoblástica aguda. Informe de un caso. Acta Pediatr Mex [Internet]. 2012 Sep-Oct [citado 2016 May 21]; 33(5):236-8. Disponible en: http://www.medigraphic.com/pdfs/actpedmex/apm-2012/apm125e
26. Acuña Pardo A, Pérez Tejeda AA, Brizuela Guillén I, Rodríguez Casales M, Estévez Miranda Y, Rúa Martínez R. Hallazgos fondoscópicos en pacientes portadores de Leucemia. Rev Misión Milagro [Internet]. 2009 Mar [citado 2016 May 21]; 3(1): Disponible en: http://www.misionmilagro.sld.cu/vol3no1/inv3109.php
27. Kanski JJ. Oftalmología Clínica. 7ma ed. España: Elsevier S.A; 2012:589.
28. Kinori M, Bielorai B, Souroujon D, Hutt D, Mizrachi IB, Huna-Baron RO. Ocular complications in children after hematopoietic stem cell transplantation without total body irradiation. Graefes Arch Clin Exp Ophthalmol. 2015.
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/
